Evidence map›Paper›PMID 33459801›Full record

ReviewJournal of molecular medicine (Berlin, Germany)2021

Genetic engineering in organoids.

Isaree Teriyapirom, Andreia S Batista-Rocha, Bon-Kyoung Koo

Abstract readReview
In one paragraph

Review in Journal of molecular medicine (Berlin, Germany), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. New developments and applications of human organoids.Nature reviews. Molecular cell biology · 2026
    Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Emerging advances in intestinal models for in vitro preclinical research.American journal of physiology. Gastrointestinal and liver physiology · 2025
    Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Organoids in breast cancer translational research: intersection of technologies.Translational breast cancer research : a journal focusing on translational research in breast cancer · 2025
    Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Isaree TeriyapiromInstitute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna Biocenter (VBC), Dr. Bohr-Gasse 3, 1030, Vienna, Austria. isaree.teriyapirom@imba.oeaw.ac.at.
Andreia S Batista-RochaInstitute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna Biocenter (VBC), Dr. Bohr-Gasse 3, 1030, Vienna, Austria.
Bon-Kyoung KooInstitute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna Biocenter (VBC), Dr. Bohr-Gasse 3, 1030, Vienna, Austria. bonkyoung.koo@imba.oeaw.ac.at.ORCID http://orcid.org/0000-0002-4134-8033

Funding

Austrian Science Fund FWF DOC 72
6 · The paper itself

Abstract

Three-dimensional organoids have been widely used for developmental and disease modeling. Organoids are derived from both adult and pluripotent stem cells. Various types are available for mimicking almost all major organs and tissues in the mouse and human. While culture protocols for stepwise differentiation and long-term expansion are well established, methods for genetic manipulation in organoids still need further standardization. In this review, we summarized different methods for organoid genetics and provide the pros and cons of each method for designing an optimal strategy.

Indexed as

OrganoidsAdult Stem CellsAnimalsAnimals, Genetically ModifiedBrainCellular Reprogramming TechniquesCRISPR-Cas SystemsGastrointestinal TractGene EditingGenetic EngineeringGene Transfer TechniquesHumansInduced Pluripotent Stem CellsKidneyLiverMammary Glands, Animal3D OrganoidsAdult Stem CellsCRISPR/Cas9Disease ModelingGenetic EngineeringOrganoid GeneticsPluripotent Stem Cells

Identifiers

PMID33459801
PMCPMC8026415

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.